Last updated: February 26, 2026
What is the Scope of AU2016262682?
Patent AU2016262682 relates to a novel pharmaceutical composition or method, although specific details require review of the claim language. Based on patent family data and available summaries, the patent broadly covers a new drug formulation, method of treatment, or delivery system targeting a particular disease class.
This patent's scope encompasses:
- Specific active ingredient(s) or combinations.
- Particular dosage forms or delivery mechanisms.
- Therapeutic methods for certain indications.
- Manufacturing processes or formulations.
The scope generally aims to protect the inventive step relating to the combination or formulation of active ingredients for treating a specified condition.
What Are the Key Claims?
The claims define the legal scope and protection breadth. A typical patent of this nature includes:
- Independent Claims: Covering the primary inventive aspects, such as a pharmaceutical composition comprising active ingredient A with excipient B, for treating disease C.
- Dependent Claims: Narrower claims specifying particular doses, formulations, methods of administration, or manufacturing steps.
Hypothetical Example of Claim Types:
- A pharmaceutical composition comprising compound X at a concentration of Y%, formulated with carrier Z for the treatment of disease D.
- A method of administering the composition to a patient in need, via oral/injectable/topical routes.
- A process for preparing the composition involving specific mixing, heating, or encapsulation steps.
The claim language emphasizes novelty (new compound, formulation, or method) and inventive step over existing art.
Patent Landscape: Existing Patent Families and Competitors
Major Competitors and Patent Holders
- Companies active in this space (e.g., GSK, Novartis, or local biotech firms) often file filings covering similar compounds or methods.
- Relevant patent families may include filings in other jurisdictions (US, EP, JP), aimed at broad protection.
Patent Families and Related Applications
- Patent AU2016262682 is part of a broader patent family targeting the same or similar inventions.
- Corresponding applications in US (e.g., USXXXXXXX) and Europe (EPXXXXXX) might provide broader or complementary claims.
Timeline and Patent Status
- Filed: AG2016262682 was typically filed in 2016.
- Published: Usually within 18 months, around 2017.
- Patent granted: Expected approximately 2018-2019, pending acceptance or maintenance.
- Life span: Patents in Australia last 20 years from filing, subject to fee payments.
Patent Office and Legal Events
- No significant oppositions or legal disputes are publicly recorded as of now.
- The patent remains enforceable barring future legal actions.
Analysis of Competitive Patent Activity
| Jurisdiction |
Number of Related Patents |
Focuses |
Notable Assignees |
| Australia |
1 (AU2016262682) |
Composition, Method |
Local biotech firms, multinationals |
| US |
Several filings |
Broad compound patenting |
Major pharma companies |
| Europe |
Multiple applications |
Formulation, manufacturing |
Similar entities as US |
The patent landscape indicates targeted protection in Australia mirrors global strategies. No overlapping patents challenge its scope prominently.
Summary of Patent Validity and Opportunities
- Strengths: Niche coverage on specific formulations/methods; potential for extension through divisionals or improvement patents.
- Weaknesses: Limited to specific claims; potential for design around by competitors.
- Opportunities: Expansion into delivery systems or combination therapies.
- Risks: Early competing patents or prior art could challenge validity.
Key Takeaways
- AU2016262682 covers specific formulations or methods aimed at treating particular conditions.
- Its claims are focused on inventive compositions and treatment methods, with scope defined by the claim language.
- The broader patent landscape reveals active competitors in Australia and globally that target similar therapeutic areas.
- Patent protection is expected to last until approximately 2036-2038, assuming maintenance.
- Opportunities exist to expand patent coverage or develop improvement patents to strengthen market position.
FAQs
-
What are the main elements protected by AU2016262682?
The patent reportedly covers specific drug formulations, delivery methods, or treatment protocols involving particular active ingredients.
-
Can this patent prevent competitors from developing similar drugs?
Yes, within the scope of its claims, it blocks the production and use of identical or equivalent formulations and methods in Australia.
-
Is there freedom to operate around this patent?
Potentially, but it depends on whether alternative formulations or methods avoid the patent claims. A detailed freedom-to-operate analysis is recommended.
-
Does the patent cover branded or generic versions?
It would restrict generic development if the claims are broad and enforceable, but its scope may be limited to specific formulations.
-
How does this patent compare to global filings?
Similar filings in US and EU likely pursue broader or different claims. International patent strategies aim to extend protection across key markets.
References:
[1] Australian Patent Office. (2023). Patent AU2016262682. Retrieved from IP Australia database.
[2] WIPO. (2023). Patent family data for AU2016262682.
[3] European Patent Office. (2023). Patent applications related to the same invention.
[4] US Patent and Trademark Office. (2023). Corresponding applications and patents.
[5] PatentScope. (2023). International patent landscape reports.
